Poland, March 19 -- Poland based Komtur Polska Sp. z o. o. has secured contract from Instytut Hematologii i Transfuzjologii for Research and experimental development services Comprehensive service for obtaining the investigational product IMP Forxiga 10mg and producing a placebo along with IMPD documentation in the HEART-DAPA-MM project G114 ABM10. The value of the contract is worth 228964500 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....